Brief: ORIC Pharmaceuticals Q1 Net Income USD -30.021 Million
05/05/2025 21:05
May 05 (Reuters) - ORIC Pharmaceuticals Q1 basic EPS USD -0.42 vs. IBES estimate USD -0.51. Q1 income from operations USD -32.718 million Q1 operating expenses USD 32.718 million
Recent news on ORIC Pharmaceuticals
See all newsBrief: Oric® Pharmaceuticals Announces Agreement With Cancer Research UK
ORIC Pharmaceuticals Q1 net loss widens on higher R&D costs
Brief: ORIC Pharmaceuticals Q1 Operating Expenses USD 39.619 Million
Brief: Oric Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
ORIC Pharmaceuticals Q4 loss narrows